Turner Investments’s Puma Biotechnology PBYI Stock Holding History

Turner Investments’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-9,885	Closed	-$2.33M	–	350
2015 Q1	$2.33M	Buy	9,885 +2,640	+36%	+$564K	0.42%	79
2014 Q4	$1.37M	Sell	7,245 -24,290	-77%	-$5.39M	0.16%	215
2014 Q3	$7.52M	Sell	31,535 -41,754	-57%	-$8.57M	0.45%	51
2014 Q2	$4.84M	Sell	73,289 -67,510	-48%	-$4.8M	0.21%	139
2014 Q1	$14.7M	Buy	140,799 +129,050	+1,098%	+$15.2M	0.39%	70
2013 Q4	$1.22M	Buy	+11,749	New	+$690K	0.02%	462

Other funds holding PBYI

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Turner Investments's PBYI Position: Q2 2015 in Review

Turner Investments sold out of Puma Biotechnology (PBYI) in Q2 2015, closing a stake of 9,885 shares — an estimated $2.33M sold.

Turner Investments first reported a position in PBYI in Q4 2013 and held it in 6 quarters. The position peaked at $14.7M in Q1 2014. 198 funds tracked by Wall St. Rank hold PBYI as of Q2 2015.

Turner Investments reported no remaining Puma Biotechnology position as of Q2 2015 after selling out during the quarter.
Turner Investments sold 9,885 Puma Biotechnology shares in Q2 2015, an estimated $2.33M.
Turner Investments first reported a position in Puma Biotechnology in Q4 2013 and held it in 6 quarters.
Turner Investments's Puma Biotechnology position peaked at $14.7M in Q1 2014.
198 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2015.

Based on Turner Investments's 13F filing for Q2 2015, filed 12 Aug 2015.